Articles with "overall population" as a keyword



Photo from wikipedia

Use of nivolumab in elderly patients with advanced squamous non-small-cell lung cancer: results from the Italian cohort of an expanded access programme.

Sign Up to like & get
recommendations!
Published in 2018 at "European journal of cancer"

DOI: 10.1016/j.ejca.2018.05.015

Abstract: AIM This analysis evaluated the efficacy and safety of nivolumab, an immune checkpoint inhibitor, in elderly patients with stage IIIB or IV squamous non-small-cell lung cancer (NSCLC) enrolled in the expanded access programme (EAP) in… read more here.

Keywords: aged years; squamous non; elderly patients; cancer ... See more keywords
Photo by ozgomz from unsplash

Anthropometric Measures and Their Relationship to Steep Cornea in the United States Population

Sign Up to like & get
recommendations!
Published in 2022 at "Cornea"

DOI: 10.1097/ico.0000000000003176

Abstract: Supplemental Digital Content is Available in the Text. Purpose: The aim of this study was to determine the relationship between anthropometric measures and steep cornea. Methods: Participants from the 1999 to 2008 US National Health… read more here.

Keywords: anthropometric measures; steep cornea; relationship; cornea ... See more keywords

Abstract CT116: Nivolumab (Nivo) vs investigator's choice (IC) in recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN): 2-yr outcomes in the overall population and PD-L1 subgroups of CheckMate 141

Sign Up to like & get
recommendations!
Published in 2018 at "Cancer Research"

DOI: 10.1158/1538-7445.am2018-ct116

Abstract: Aim: Nivo is the only immunotherapy to significantly improve overall survival (OS) in patients (pts) with R/M SCCHN who have progressed on or after platinum-based therapy. Here we report long-term data from the randomized, open-label,… read more here.

Keywords: recurrent metastatic; checkmate 141; nivolumab nivo; choice recurrent ... See more keywords
Photo by krakenimages from unsplash

Efficacy and Safety of Dabigatran in the Treatment and Secondary Prophylaxis of Children with Venous Thromboembolism and Thrombophilia

Sign Up to like & get
recommendations!
Published in 2020 at "Blood"

DOI: 10.1182/blood-2020-136695

Abstract: Background: Thrombophilia in children is characterized by hypercoagulability and increased frequency of thrombotic events (Young G, et al. Circulation. 2008;118:1373-1378; Kenet G, et al. Circulation. 2010;121:1838-1847). Recently, phase IIb/III clinical trials in children with venous… read more here.

Keywords: boehringer ingelheim; vte; children thrombophilia; overall population ... See more keywords